Is cardiac resynchronization therapy an antiarrhythmic therapy for atrial fibrillation? A systematic review and meta-analysis

Current Cardiology Reports

Volumn 15, Issue 2, 2013, Pages

  Hess, Paul L ^a,b   Jackson, Kevin P ^b   Hasselblad, Vic ^a   Al Khatib, Sana M ^a,b  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b DUKE UNIVERSITY HOSPITAL   (United States)

Author keywords

Atrial fibrillation; Cardiac resynchronization therapy

Indexed keywords

CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL STUDY; DISEASE COURSE; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INCIDENCE; META ANALYSIS; OBSERVATIONAL STUDY; PAROXYSMAL HEART ATRIUM FIBRILLATION; PREVALENCE; PROSPECTIVE STUDY; REVIEW; SINUS RHYTHM; SYSTEMATIC REVIEW; HEART ATRIUM FIBRILLATION; TREATMENT OUTCOME;

ATRIAL FIBRILLATION; CARDIAC RESYNCHRONIZATION THERAPY; HUMANS; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 84879312079     PISSN: 15233782     EISSN: 15343170     Source Type: Journal    
DOI: 10.1007/s11886-012-0330-6     Document Type: Review

References (39)

1. Braunwald E. Shattuck lecture-cardiovascular medicine at the turn of the millenium: triumphs, concerns, and opportunities. N Engl J Med. 1997;337:1360-9. (Pubitemid 27467771)
2. Lloyd-Jones DM, Larson MG, Leip EP, et al. Lifetime risk for developing congestive heart failure: the framingham heart study. Circulation. 2002;106:3068-72. (Pubitemid 35440290)
3. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics-2011 update: a report from the american heart association. Circulation. 2011;123:e18-e209.
4. Benjamin EJ, Wolf PA, D'agostino RB, et al. Impact of atrial fibrillation on the risk of death: the framingham heart study. Circulation. 1998;98:946-52. (Pubitemid 28446646)
5. Roger VL, Weston SA, Redfield MM, et al. Trends in heart failure incidence and survival in a community-based population. JAMA. 2004;292:344-50. (Pubitemid 38944258)
6. De Ferrari GM, Klersy C, Ferrero P, et al. Atrial fibrillation in heart failure patients: prevalence in daily practice and effect on the severity of symptoms. Data from the alpha study registry. Eur J Heart Fail. 2007;9:502-9. (Pubitemid 46561482)
7. Olsson LG, Swedberg K, Ducharme A, et al. Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the candesartan in heart failure-Assessment of reduction in mortality and morbidity (charm) program. J Am Coll Cardiol. 2006;47:1997-2004.
8. Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002;346:1845-53. (Pubitemid 34603028)
9. Linde C, Leclercq C, Rex S, et al. Long-Term benefits of biventricular pacing in congestive heart failure: results from the multisite stimulation in cardiomyopathy (mustic) study. J Am Coll Cardiol. 2002;40:111-8. (Pubitemid 34701385)
10. Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140-50.
11. Cleland JGF, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352:1539-49. (Pubitemid 40517094)
12. Lindenfeld J, Feldman AM, Saxon L, et al. Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with new york heart association class iv heart failure. Circulation. 2007;115:204-12. (Pubitemid 46105719)
13. Epstein AE, Dimarco JP, Ellenbogen KA, et al. Acc/aha/hrs 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the american college of cardiology/american heart association task force on practice guidelines (writing committee to revise the acc/aha/naspe 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices) developed in collaboration with the american association for thoracic surgery and society of thoracic surgeons. J Am Coll Cardiol. 2008;51:e1-62.
14. Upadhyay GA, Choudhry NK, Auricchio A, et al. Cardiac resynchronization in patients with atrial fibrillation: a metaanalysis of prospective cohort studies. J Am Coll Cardiol. 2008;52:1239-46.
15. Wilton SB, Leung AA, Ghali WA, et al. Outcomes of cardiac resynchronization therapy in patients with versus those without atrial fibrillation: a systematic review and meta-Analysis. Heart Rhythm. 2011;8:1088-94.
16. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-Analyses: the prisma statement. Ann Intern Med. 2009;151:264-9. W64.
17. Dersimonian R, Laird N. Meta-Analysis in clinical trials. Control Clin Trials. 1986;7:177-88. (Pubitemid 17189972)
18. Luedorff G, Grove R, Kowalski M, et al. Impact of chronic atrial fibrillation in patients with severe heart failure and indication for crt: data of two registries with 711 patients (1999-2006 and 2007-6/2008). Herzschrittmacherther Elektrophysiol. 2011;22:226-32.
19. Gasparini M, Steinberg JS, Arshad A, et al. Resumption of sinus rhythm in patients with heart failure and permanent atrial fibrillation undergoing cardiac resynchronization therapy: A longitudinal observational study. Eur Heart J. 2010;31:976-83. This study showed that approximately one in every ten HF patients with permanent AF may experience conversion to normal sinus rhythm after CRT placement.
20. Hauck M, Bauer A, Voss F, et al. Effect of cardiac resynchronization therapy on conversion of persistent atrial fibrillation to sinus rhythm. Clin Res Cardiol. 2009;98:189-94.
21. Lellouche N, Diego CD, Vaseghi M, et al. Cardiac resynchronization therapy response is associated with shorter duration of atrial fibrillation. PACE. 2007; 30:1363-8
22. Kies P, Leclercq C, Bleeker GB, et al. Cardiac resynchronisation therapy in chronic atrial fibrillation: impact on left atrial size and reversal to sinus rhythm. Heart. 2006;92:490-4.
23. Yannopoulos D, Lurie KG, Sakaguchi S, et al. Reduced atrial tachyarrhythmia susceptibility after upgrade of conventional implanted pulse generator to cardiac resynchronization therapy in patients with heart failure. J Am Coll Cardiol. 2007;50:1246-51. (Pubitemid 47405134)
24. Adelstein EC, Saba S. Burden of atrial fibrillation after cardiac resynchronization therapy. Am J Cardiol. 2007;100:268-72. (Pubitemid 47041999)
25. Hugl B, Bruns HJ, Unterberg-Buchwald C, et al. Atrial fibrillation burden during the post-implant period after crt using device-based diagnostics. J Cardiovasc Electrophysiol. 2006;17:813-7. (Pubitemid 44079738)
26. Brenyo A, Link MS, Barsheshet A, et al. Cardiac resynchronization therapy reduces left atrial volume and the risk of atrial tachyarrhythmias in madit-crt (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy). J Am Coll Cardiol. 2011;58:1682-9.
27. Hoppe UC, Casares JM, Eiskjaer H, et al. Effect of cardiac resynchronization on the incidence of atrial fibrillation in patients with severe heart failure. Circulation. 2006;114:18-25. (Pubitemid 44305270)
28. Fung JW, Yu CM, Chan JY, et al. Effects of cardiac resynchronization therapy on incidence of atrial fibrillation in patients with poor left ventricular systolic function. Am J Cardiol. 2005;96:728-31. (Pubitemid 41213305)
29. D'ascia SL, D'ascia C, Marino V, et al. Cardiac resynchronisation therapy response predicts occurrence of atrial fibrillation in nonischaemic dilated cardiomyopathy. Int J Clin Pract. 2011;65:1149-55.
30. Li D, Fareh S, Leung TK, et al. Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. Circulation. 1999;100:87-95. (Pubitemid 29297945)
31. Saxon LA. Does cardiac resynchronization therapy reduce the incidence of atrial fibrillation, and does atrial fibrillation compromise the cardiac resynchronization therapy effect? Heart Rhythm. 2007;4:S31-3.
32. Bleeker GB, Schalij MJ, Holman ER, et al. Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy. Am J Cardiol. 2006;98:230-5. (Pubitemid 43975500)
33. Linde C, Abraham WT, Gold MR, et al. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol. 2008;52:1834-43.
34. Moss AJ, Hall WJ, Cannom DS, et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med. 2009;361:1329-38. This study showed that CRT reduces the risk of HF events among patients with New York Heart Association Class III symptoms, an ejection fraction 130 milliseconds.
35. Tang ASL, Wells GA, Talajic M, et al. Cardiac-resynchronization therapy for mild-To-moderate heart failure. N Engl J Med. 2010;363:2385-95. This study showed that CRT reduces the risks of death and HF hospitalization among patients with New York Heart Association Class II-III symptoms, an ejection fraction 120 milliseconds.
36. Goldenberg I, Moss AJ, Hall WJ, et al. Predictors of response to cardiac resynchronization therapy in the multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy (madit-crt). Circulation. 2011;124:1527-36. This study identified seven factors associated with echocardiographic response to CRT in combination with an implantable cardioverterdefibrillator. These factors can be used to select patients likely to benefit from CRT.
37. Zareba W, Klein H, Cygankiewicz I, et al. Effectiveness of cardiac resynchronization therapy by qrs morphology in the multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (madit-crt). Circulation. 2011;123:1061-72.
38. Gasparini M, Auricchio A, Regoli F, et al. Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation. J Am Coll Cardiol. 2006;48:734-43. (Pubitemid 44175735)
39. Ganesan AN, Brooks AG, Roberts-Thomson KC, et al. Role of av nodal ablation in cardiac resynchronization in patients with coexistent atrial fibrillation and heart failure a systematic review. J Am Coll Cardiol. 2012;59:719-26.